115 related articles for article (PubMed ID: 9568027)
1. Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies.
Kulski JK; Sadleir JW; Kelsall SR; Cicchini MS; Shellam G; Peng SW; Qi YM; Galloway DA; Zhou J; Frazer IH
Virology; 1998 Apr; 243(2):275-82. PubMed ID: 9568027
[TBL] [Abstract][Full Text] [Related]
2. Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.
Christensen ND; Cladel NM; Reed CA; Budgeon LR; Embers ME; Skulsky DM; McClements WL; Ludmerer SW; Jansen KU
Virology; 2001 Dec; 291(2):324-34. PubMed ID: 11878901
[TBL] [Abstract][Full Text] [Related]
3. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies.
Christensen ND; Dillner J; Eklund C; Carter JJ; Wipf GC; Reed CA; Cladel NM; Galloway DA
Virology; 1996 Sep; 223(1):174-84. PubMed ID: 8806551
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies to HPV-6 L1 virus-like particles identify conformational and linear neutralizing epitopes on HPV-11 in addition to type-specific epitopes on HPV-6.
Christensen ND; Reed CA; Cladel NM; Hall K; Leiserowitz GS
Virology; 1996 Oct; 224(2):477-86. PubMed ID: 8874508
[TBL] [Abstract][Full Text] [Related]
5. Mutations on the FG surface loop of human papillomavirus type 16 major capsid protein affect recognition by both type-specific neutralizing antibodies and cross-reactive antibodies.
Carpentier GS; Fleury MJ; Touzé A; Sadeyen JR; Tourne S; Sizaret PY; Coursaget P
J Med Virol; 2005 Dec; 77(4):558-65. PubMed ID: 16254978
[TBL] [Abstract][Full Text] [Related]
6. Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6.
Kawana K; Yoshikawa H; Taketani Y; Yoshiike K; Kanda T
J Virol; 1999 Jul; 73(7):6188-90. PubMed ID: 10364381
[TBL] [Abstract][Full Text] [Related]
7. Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses.
Combita AL; Touzé A; Bousarghin L; Christensen ND; Coursaget P
J Virol; 2002 Jul; 76(13):6480-6. PubMed ID: 12050360
[TBL] [Abstract][Full Text] [Related]
8. A surface immunodeterminant of human papillomavirus type 16 minor capsid protein L2.
Kawana K; Matsumoto K; Yoshikawa H; Taketani Y; Kawana T; Yoshiike K; Kanda T
Virology; 1998 Jun; 245(2):353-9. PubMed ID: 9636375
[TBL] [Abstract][Full Text] [Related]
9. Expression of HPV6b L1/EBV LMP2 multiepitope and immunogenicity in mice.
Zhu S; Xue X; Liu J; Lu L; Zhao P; Wang J; Li W; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2010 Aug; 42(8):515-21. PubMed ID: 20705592
[TBL] [Abstract][Full Text] [Related]
10. Identification of type-specific and cross-reactive neutralizing conformational epitopes on the major capsid protein of human papillomavirus type 31.
Fleury MJ; Touzé A; Alvarez E; Carpentier G; Clavel C; Vautherot JF; Coursaget P
Arch Virol; 2006 Aug; 151(8):1511-23. PubMed ID: 16508703
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
12. Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes.
Cason J; Patel D; Naylor J; Lunney D; Shepherd PS; Best JM; McCance DJ
J Gen Virol; 1989 Nov; 70 ( Pt 11)():2973-87. PubMed ID: 2479716
[TBL] [Abstract][Full Text] [Related]
13. Two amino acid residues confer type specificity to a neutralizing, conformationally dependent epitope on human papillomavirus type 11.
Ludmerer SW; Benincasa D; Mark GE
J Virol; 1996 Jul; 70(7):4791-4. PubMed ID: 8676509
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HPV16 L1 loop domains in the formation of a type-specific, conformational epitope.
Olcese VA; Chen Y; Schlegel R; Yuan H
BMC Microbiol; 2004 Jul; 4():29. PubMed ID: 15260888
[TBL] [Abstract][Full Text] [Related]
15. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies.
Bishop B; Dasgupta J; Klein M; Garcea RL; Christensen ND; Zhao R; Chen XS
J Biol Chem; 2007 Oct; 282(43):31803-11. PubMed ID: 17804402
[TBL] [Abstract][Full Text] [Related]
16. Induction of immune responses against human papillomaviruses by hypervariable epitope constructs.
Reddy KJ; Banapour B; Anderson DE; Lee SH; Marquez JP; Carlos MP; Torres JV
Immunology; 2004 Jun; 112(2):321-7. PubMed ID: 15147575
[TBL] [Abstract][Full Text] [Related]
17. Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein.
Selvey LA; Tindle RW; Geysen HM; Haller CJ; Smith JA; Frazer IH
J Immunol; 1990 Nov; 145(9):3105-10. PubMed ID: 1698872
[TBL] [Abstract][Full Text] [Related]
18. Modification of human papillomavirus-like particle vaccine by insertion of the cross-reactive L2-epitopes.
Kondo K; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
J Med Virol; 2008 May; 80(5):841-6. PubMed ID: 18360909
[TBL] [Abstract][Full Text] [Related]
19. The N-terminal region of the human papillomavirus L2 protein contains overlapping binding sites for neutralizing, cross-neutralizing and non-neutralizing antibodies.
Rubio I; Seitz H; Canali E; Sehr P; Bolchi A; Tommasino M; Ottonello S; Müller M
Virology; 2011 Jan; 409(2):348-59. PubMed ID: 21074234
[TBL] [Abstract][Full Text] [Related]
20. [Anti-peptide antibodies specifically recognize the L1 protein of human papilloma virus type 31].
Andreev SM; Giliazova AV; Khaitov MR; Kozlov DG
Bioorg Khim; 2012; 38(6):667-75. PubMed ID: 23547470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
